Adebrelimab and Chidamide for Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Cancer, Adult

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jinling Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
Contact: Study coordinator (Xiufeng liu, Prof. M.D.) · liuxiufeng@csco.org.cn · 025-80860114
Contact: Study coordinator (Jianping Li, Prof. M.D.)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Solid Tumor, Adult · Colorectal Cancer · NSCLC

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · La Jolla, United States

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Pancreatic Cancer, Adult · Gastroesophageal Cancer (GC)

Abroad (travel likely)RecruitingPHASE2

Copenhagen, Denmark

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma (PDAC) · Cancer of Pancreas · Pancreatic Cancer, Adult

Abroad (travel likely)RecruitingPHASE2

Chapel Hill, United States

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

Solid Tumor, Adult · Pancreatic Cancer · Virus-associated Tumors

Abroad (travel likely)RecruitingPHASE2

Bordeaux, France · Brest, France